
Sunscreens and hormone health: What you should know before you apply
But dermatologists stress that this does not mean sunscreens are unsafe or should be avoided altogether.Rather, it's a reminder to be more informed about what we apply on our skin every day."The concern for safety and effectiveness of sunscreen ingredients has been heightened after recent evidence of their measurable systemic absorption following topical application," Dr. Sarita Sanke, dermatologist at Yashoda Super Speciality Hospitals, Kaushambi, told IndiaToday.in.Among the ingredients drawing attention are oxybenzone and octinoxate, two UV filters widely used for their ability to absorb harmful UVB and UVA rays of the sun.However, both have also been found in blood, urine, breast milk, and even amniotic fluid, raising questions about their possible impact on hormonal balance and foetal development.While these ingredients are not banned and continue to be approved for use in many countries, including India, doctors say more research is needed.advertisementThe US FDA (Food and Drugs Administration) has highlighted the importance of further evaluating all sunscreen ingredients with systemic absorption levels over 0.5 ng/mL, Dr. Sanke informed.DOES SUNSCREEN DISRUPT HOMONES?Some studies have pointed to possible associations with thyroid changes, pubertal development, kidney function, and immune health, though these findings remain inconclusive.Other ingredients under scrutiny include homosalate, avobenzone, octisalate, and octocrylene, all commonly found in many commercial sunscreen formulations and approved by the US FDA.However, the research is far from definitive.'Octinoxate and oxybenzone are also present in plastic packaging, water, air, and cosmetics. While detected in body fluids, their systemic exposure hasn't been proven harmful in humans,' said Bengaluru-based dermatologist Dr. Divya Sharma.She added that sunscreen safety is still under active investigation globally, but no regulatory agency has so far called for discontinuing their use.WHAT SHOULD CONSUMERS DO?Both Dr. Sanke and Dr. Sharma suggest that mineral sunscreens, which contain zinc oxide or titanium dioxide, could be a safer alternative for those concerned.These ingredients physically block UV rays rather than absorbing them, and while they too can penetrate the skin in small amounts, the current data do not indicate toxicity.In fact, many sunscreen formulations available in India have already phased out older ingredients like PABA and triethanolamine, which were previously linked to safety concerns.advertisementWhile some studies have raised concerns about sunscreen chemicals affecting fish microbiota and aquatic systems, no evidence yet links these effects to human health.Dermatologists advise that sunscreens are a critical defence against skin cancer and premature ageing, especially in a country like India where UV indices frequently soar.Avoiding sunscreen entirely out of fear would be misguided, doctors warn.Instead, the advice is to choose wisely, look at ingredient labels, and opt for mineral-based products where possible, particularly for children, pregnant women, or those with sensitive skin.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Hindu
25 minutes ago
- The Hindu
Cancer hospital celebrates first anniversary of BMT unit
Homi Bhabha Cancer Hospital and Research Centre (HBCHRC), Tata Memorial Centre, Visakhapatnam, celebrated the first anniversary of its Bone Marrow Transplant (BMT) Unit on Tuesday. The event brought together doctors, staff, patients, and families to commemorate the unit's milestones. Since its inception, the centre has completed 18 transplants—13 autologous and 5 allogenic—and recently introduced a TBI-based conditioning regimen, available in only a few centres in Andhra Pradesh. HBCHRC Director Umesh Mahantshetty said the BMT Unit has been a 'symbol of resilience and teamwork,' particularly in making advanced treatments accessible to underprivileged patients. He acknowledged the support of the Ministry of Health and Family Welfare, TMC patient welfare funds, Indian Cancer Society, and local philanthropists. Future plans include introducing haploidentical transplantations and CAR-T cell therapy.


The Hindu
3 hours ago
- The Hindu
NHRC directs Telangana Education dept. for report in student's death
The National Human Rights Commission (NHRC) on Tuesday directed Secretary (Education) Yogitha Rana for a comprehensive report concerning the death of a 16-year-old girl in Government Ashram High School for Girls in Wankidi, Komaram Bheem Asifabad district, last year. The girl along with two other students were admitted to Nizam's Institute of Medical Sciences with severe gastroenteritis symptoms, after they reportedly consumed food from their school. While the latter two were discharged, the girl in critical condition died while being treated on November 25. The NHRC, responding to Hyderabad-based advocate Rama Rao Immaneni's petition, opened an investigation and directed Ms. Yogitha Rana to submit the report within four weeks.


The Hindu
3 hours ago
- The Hindu
Customers may bear some cost of U.S. tariff rise, says Natco Pharma CEO
For Indian pharma industry, there is bound to be disruption initially in the event of the U.S. imposing tariff but over time the drugmakers will look to pass on some of the impact to the customers, a top executive of a well known company said. With the U.S. market accounting for a significant part of the portfolio, the industry, however, has to brace for it, Natco Pharma vice-chairman and CEO Rajeev Nannapaneni responded to queries on the impact, in the event of the levy, during an earnings call recently. who had earlier this year highlighted how it is important for drugmakers to get a front-end manufacturing foothold in the U.S. as a counter measure, said the company needs to readjust strategy based on the policy. U.S. is still the most important pharmaceutical market in the world, particularly for some products that account for around two-third of the business. 'You can't ignore 60-70% of the business and run your business,' he said, while pointing out at Natco Pharma's ongoing efforts to build a business outside U.S. The Hyderabad-based firm had recently announced it will be acquiring 36% stake in South African pharmaceutical company Adcock Ingram Holdings (AIHL) for $226 million (around ₹2,000 crore). Over time, the investment will contribute to a 'significant part of our base earnings'... I would believe South Africa will easily be about 15-25% of the base earnings. So we are diversifying away from the U.S. as well. It's not that we are not. But again, you can't ignore U.S. at the same time. So you have to play both the cards,' he said. To another query related on impact of tariffs, sought to explain how it would not be easy to pass through immediately considering the contracts and pricing. But, in the long run, 'we would like to pass it on to our customers because the margins that we work on most of our products are very low. So, there will be some little bit of disruption initially, but I think eventually we will figure out after a quarter.'